Form 4: Director O'Quinn Receives Restricted Stock Grant

Marvin R. O'Quinn, a Director of American Healthcare REIT, Inc., was granted 2,594 shares of restricted common stock upon his re-election to the board.

Summary

• Marvin R. O'Quinn, a Director of American Healthcare REIT, Inc. (AHR), received a grant of 2,594 shares of restricted common stock on June 24, 2026.
• This grant was made upon his re-election to the board of directors.
• The restricted shares are set to vest on June 24, 2027.
• Following this transaction, O'Quinn beneficially owns 20,656 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine stock grant to a director upon re-election, which is standard compensation and does not indicate significant positive or negative developments for the company.

Positives

• Director O'Quinn's re-election and subsequent stock grant indicate continued confidence and commitment from management.
• The grant of restricted stock aligns the director's interests with those of shareholders, as the shares vest over time.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future financial performance. It solely reports a stock grant to a director.

Industry Context

StockSavvy.ai notes that grants of restricted stock to directors are a common practice in the healthcare REIT industry as a form of compensation and to incentivize long-term alignment with shareholder value.

Stakeholder Impact

• Shareholders: The grant of restricted stock aligns director compensation with long-term shareholder value, as the shares vest over time.
• Management: Reinforces the director's commitment to the company.

Next Steps

• The restricted stock granted will vest on June 24, 2027.

Key Dates

Keywords

Form 4, SEC Filing, American Healthcare REIT, AHR, Director Compensation, Restricted Stock, Insider Transaction, Marvin R. O'Quinn